Integra LifeSciences (IART) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts IART Hot Sheet
Join SI Premium – FREE
Integra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.93, $0.04 better than the analyst estimate of $0.89. Revenue for the quarter came in at $250.3 million versus the consensus estimate of $249.3 million.
GUIDANCE:
Integra LifeSciences sees FY2016 EPS of $3.47-$3.53, versus the consensus of $3.48.
For earnings history and earnings-related data on Integra LifeSciences (IART) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- Investar Holding (ISTR) Tops Q3 EPS by 1c
- National Bankshares Inc (NKSH) Misses Q3 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
